|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.800 USD | +0.91% |
|
-1.02% | +8.18% |
| 06-09 | Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases | MT |
| 05-26 | Cartesian Therapeutics, Inc. Announces Executive Changes | CI |
| Market Cap | 229M 199M 185M 170M 322M 21.88B 326M 2.19B 858M 10.89B 861M 842M 36.52B | P/E 2026 * |
-1.88x | P/E 2027 * | -2.04x |
|---|---|---|---|---|---|
| Enterprise Value | 85.68M 74.48M 69.32M 63.65M 120M 8.18B 122M 817M 321M 4.07B 322M 315M 13.65B | EV / Sales 2026 * |
155x | EV / Sales 2027 * | -182x |
| Free-Float |
46.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | +0.91% | ||
| 1 week | -1.02% | ||
| 1 month | -26.35% | ||
| 3 months | +25.40% | ||
| 6 months | +14.87% | ||
| Current year | +8.18% |
| 1 week | 7.27 |  | 7.91 |
| 1 month | 7.27 | | 10.84 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 12.57 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/01/26 | Sell | Chief Technology Officer | 3,573 | 0.0137% | ||
| 06/01/26 | Sell | Chief Executive Officer | 23,766 | 0.0914% | ||
| 06/01/26 | Sell | Chief Financial Officer | 10,591 | 0.0407% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | -1.02% | -36.74% | - | 229M | |
| +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +63.59% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| -0.41% | -0.47% | +23.25% | -15.15% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -30.63% | 17.56B | |
| -2.65% | -8.55% | +16.18% | +544.61% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.69% | -3.52% | +28.25% | +158.24% | 23.41B | |
| Weighted average by Cap. | -0.26% | -2.96% | +30.50% | +119.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552K 480K 447K 410K 775K 52.72M 787K 5.27M 2.07M 26.25M 2.07M 2.03M 88M | 402K 349K 325K 298K 563K 38.33M 572K 3.83M 1.5M 19.08M 1.51M 1.47M 63.98M |
| Net income | -122M -106M -99M -90.89M -172M -11.68B -174M -1.17B -458M -5.81B -460M -449M -19.5B | -131M -114M -106M -97.11M -183M -12.48B -186M -1.25B -489M -6.21B -491M -480M -20.83B |
| Net Debt | -144M -125M -116M -107M -201M -13.7B -204M -1.37B -537M -6.82B -539M -527M -22.87B | -302M -263M -244M -224M -424M -28.84B -430M -2.88B -1.13B -14.36B -1.13B -1.11B -48.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$7.800 | +0.91% | 140,249 |
| 30/07/26 | US$7.730 | +4.18% | 98,714 |
| 29/07/26 | US$7.420 | -3.01% | 168,818 |
| 28/07/26 | US$7.650 | -1.80% | 106,229 |
| 27/07/26 | US$7.790 | -1.14% | 79,053 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
